Optical metabolic imaging quantifies heterogeneous cell populations

Biomedical Optics Express

Volumn 6, Issue 2, 2015, Pages 559-573

  Walsh, Alex J ^a   Skala, Melissa C ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMINE COMPOUNDS; CELL CULTURE; CELL PROLIFERATION; CELLS; DISEASES; METABOLISM; TUMORS;

BREAST CANCER CELLS; CELL SUBPOPULATIONS; FLUORESCENCE INTENSITIES; FLUORESCENCE LIFETIMES; HETEROGENEOUS POPULATIONS; MIXED GAUSSIAN DISTRIBUTIONS; MOLECULAR SPECIFICITY; SEPARATION DISTANCES;

FLUORESCENCE IMAGING;

FLAVINE ADENINE NUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; BREAST CANCER CELL LINE; CELL FUNCTION; CELL HETEROGENEITY; CELL METABOLISM; CELL POPULATION; CELL STRUCTURE; CELL SUBPOPULATION; COCULTURE; CULTURE MEDIUM; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; LIFESPAN; MATHEMATICAL MODEL; NEOPLASM; NORMAL DISTRIBUTION; OPTICAL METABOLIC IMAGING; OXIDATION REDUCTION POTENTIAL; SAMPLE SIZE; SIMULATION;

EID: 84942363877     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.6.000559     Document Type: Article

References (19)

1. R. Fisher, L. Pusztai, and C. Swanton, “Cancer heterogeneity: implications for targeted therapeutics,” Br. J. Cancer 108(3), 479–485 (2013).
2. D. J. Kiviet, P. Nghe, N. Walker, S. Boulineau, V. Sunderlikova, and S. J. Tans, “Stochasticity of metabolism and growth at the single-cell level,” Nature 514(7522), 376–379 (2014).
3. K. J. Cheung, E. Gabrielson, Z. Werb, and A. J. Ewald, “Collective invasion in breast cancer requires a conserved basal epithelial program,” Cell 155(7), 1639–1651 (2013).
4. V. Almendro, Y. K. Cheng, A. Randles, S. Itzkovitz, A. Marusyk, E. Ametller, X. Gonzalez-Farre, M. Muñoz, H. G. Russnes, A. Helland, I. H. Rye, A. L. Borresen-Dale, R. Maruyama, A. van Oudenaarden, M. Dowsett, R. L. Jones, J. Reis-Filho, P. Gascon, M. Gönen, F. Michor, and K. Polyak, “Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity,” Cell Rep 6(3), 514–527 (2014).
5. K. Polyak, “Tumor Heterogeneity Confounds and Illuminates: A case for Darwinian tumor evolution,” Nat. Med. 20(4), 344–346 (2014).
6. J. E. Visvader and G. J. Lindeman, “Cancer stem cells in solid tumours: accumulating evidence and unresolved questions,” Nat. Rev. Cancer 8(10), 755–768 (2008).
7. I. Georgakoudi and K. P. Quinn, “Optical imaging using endogenous contrast to assess metabolic state,” Annu. Rev. Biomed. Eng. 14(1), 351–367 (2012).
8. B. Chance, B. Schoener, R. Oshino, F. Itshak, and Y. Nakase, “Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals,” J. Biol. Chem. 254(11), 4764–4771 (1979).
9. A. J. Walsh, R. S. Cook, H. C. Manning, D. J. Hicks, A. Lafontant, C. L. Arteaga, and M. C. Skala, “Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer,” Cancer Res. 73(20), 6164–6174 (2013).
10. J. Lakowicz, Principles of Fluorescence Spectroscopy (Plenum Publishers, New York, 1999).
11. J. R. Lakowicz, H. Szmacinski, K. Nowaczyk, and M. L. Johnson, “Fluorescence Lifetime Imaging of Free and Protein-Bound NADH,” Proc. Natl. Acad. Sci. U.S.A. 89(4), 1271–1275 (1992).
12. F. Tanaka, N. Tamai, and I. Yamazaki, “Picosecond-resolved fluorescence spectra of D-amino-acid oxidase. A new fluorescent species of the coenzyme,” Biochemistry 28(10), 4259–4262 (1989).
13. A. Walsh, R. S. Cook, B. Rexer, C. L. Arteaga, and M. C. Skala, “Optical imaging of metabolism in HER2 overexpressing breast cancer cells,” Biomed. Opt. Express 3(1), 75–85 (2012).
14. A. J. Walsh, R. S. Cook, M. E. Sanders, L. Aurisicchio, G. Ciliberto, C. L. Arteaga, and M. C. Skala, “Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer,” Cancer Res. 74(18), 5184–5194 (2014).
15. M. C. Skala, K. M. Riching, D. K. Bird, A. Gendron-Fitzpatrick, J. Eickhoff, K. W. Eliceiri, P. J. Keely, and N. Ramanujam, “In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia,” J. Biomed. Opt. 12(2), 024014 (2007).
16. M. C. Skala, K. M. Riching, A. Gendron-Fitzpatrick, J. Eickhoff, K. W. Eliceiri, J. G. White, and N. Ramanujam, “In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia,” Proc. Natl. Acad. Sci. U.S.A. 104(49), 19494–19499 (2007).
17. W. Pan, J. Lin, and C. T. Le, “Model-based cluster analysis of microarray gene-expression data,” Genome Biol. 3(2), H0009 (2002).
18. H. Akaike, “A new look at the statistical model identification,” IEEE Trans. Automatic Control 19(6), 716–723 (1974).
19. A. J. Walsh, K. M. Poole, C. L. Duvall, and M. C. Skala, “Ex vivo optical metabolic measurements from cultured tissue reflect in vivo tissue status,” J. Biomed. Opt. 17(11), 116015 (2012).